Dr Reddy’s Rises After US FDA Nod for Cancer Biosimilar
Dr Reddy’s Laboratories touched a day high of ₹1,182 after the company disclosed in an exchange filing that it received US FDA approval. The approval...
Tag : USFDA
Zydus Shares Slip Even as USFDA Clears Phase III Trial
Zydus Lifesciences shares slipped 2% on the NSE on Thursday, even after the company cleared a big regulatory hurdle for a new drug trial. The...
Glenmark Gets USFDA Nod to Expand RYALTRIS Use
Glenmark touched a day’s high of Rs 2,249.30 on the NSE on Tuesday, after the USFDA approved a wider use of its allergy spray RYALTRIS....
Alembic Pharma Falls 2% on USFDA Warning Letter
Alembic Pharmaceuticals shares slipped as much as 2% on Tuesday, 14 July, touching a day low of Rs 814.55 on the NSE. The fall came...
Glenmark, Granules Rally on US Drug Approvals
Glenmark and Granules India shares rose Monday, hitting fresh highs after both drugmakers landed key US regulatory approvals. Both moves were driven by news out...
Zydus Lifesciences Rises 2% on Sterling Biotech Deal Update
Zydus Lifesciences jumps to Rs 1,125 on 29 June, up 2%, after extending its Sterling Biotech API acquisition deadline to 30 September 2026. Active Pharmaceutical...
Jubilant Pharmova Arm Gets USFDA Nod for Antacid Drug
Shares of Jubilant Pharmova Limited touched Rs 985.95 on 25 June after its arm won a tentative USFDA nod for an antacid drug. Most people...
Lupin Shares End 3% Higher on USFDA Nod for Schizophrenia, Bipolar Disorder Drug
Shares of Lupin Ltd ended 3% higher after hitting a day’s high of Rs 1,953.80 on 3rd September, following the company’s announcement that it has...
Zydus Lifesciences Gets Four USFDA Observations at Baddi Plant, Ahmedabad Unit Clears Inspection; Shares Flat
Shares of Zydus Lifesciences Ltd are trading flat after touching a day’s high of Rs 1,002.85 on 14th August. This came after the company said...
Marksans Pharma Gets USFDA Nod for Acid Reflux Drug, Shares Trade Flat
Shares of Marksans Pharma Ltd were trading flat on 8th August after touching a day’s high of Rs 217.49, despite the company securing final approval...